MeSH term
Frequency | Condition_Probility | Adult | 12 | 0.0 |
Alleles | 5 | 0.0 |
Carrier Proteins/*genetics | 19 | 1.0 |
Case-Control Studies | 4 | 0.0 |
Cohort Studies | 5 | 0.0 |
Crohn Disease/*genetics | 9 | 24.0 |
Female | 17 | 0.0 |
Gene Frequency | 7 | 0.0 |
Genotype | 12 | 0.0 |
Haplotypes | 6 | 0.0 |
Humans | 31 | 0.0 |
*Intracellular Signaling Peptides and Proteins | 25 | 3.0 |
Male | 17 | 0.0 |
Molecular Sequence Data | 5 | 0.0 |
Mutation | 4 | 0.0 |
Phenotype | 8 | 0.0 |
Polymorphism, Single Nucleotide | 4 | 0.0 |
Research Support, Non-U.S. Gov't | 24 | 0.0 |
*Variation (Genetics) | 3 | 0.0 |
Adolescent | 5 | 0.0 |
Aged | 6 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
Child | 5 | 0.0 |
DNA Mutational Analysis | 3 | 0.0 |
Middle Aged | 8 | 0.0 |
Chromosomes, Human, Pair 16 | 3 | 2.0 |
Frameshift Mutation | 2 | 0.0 |
Genetic Markers | 2 | 0.0 |
Genetic Predisposition to Disease | 6 | 0.0 |
Polymorphism, Genetic | 4 | 0.0 |
Colitis, Ulcerative/*genetics | 3 | 11.0 |
Intracellular Signaling Peptides and Proteins/*genetics | 3 | 30.0 |
Risk Factors | 3 | 0.0 |
Amino Acid Substitution | 2 | 0.0 |
Carrier Proteins/genetics | 2 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Comparative Study | 3 | 0.0 |
Crohn Disease/epidemiology/*genetics | 2 | 40.0 |
Membrane Proteins/*genetics | 2 | 0.0 |
Pedigree | 2 | 0.0 |
Amino Acid Sequence | 2 | 0.0 |
Chromosomes, Human, Pair 5/*genetics | 2 | 2.0 |
Hela Cells | 2 | 0.0 |
Linkage Disequilibrium | 3 | 0.0 |
Prevalence | 2 | 0.0 |
Risk | 2 | 0.0 |
Animals | 2 | 0.0 |
*Mutation | 6 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 5 | 0.0 |
Lipopolysaccharides/pharmacology | 3 | 0.0 |
*Genetic Predisposition to Disease | 6 | 0.0 |
Variation (Genetics) | 5 | 0.0 |
Microsatellite Repeats | 2 | 0.0 |
Crohn Disease/ethnology/*genetics | 2 | 66.0 |
Genetic Predisposition to Disease/genetics | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
NF-kappa B/metabolism | 2 | 0.0 |
